Shay Capital’s GoodRx Holdings GDRX Stock Holding History

Shay Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,000	Closed	-$46.5K	–	531
2025 Q3	$46.5K	Buy	+11,000	New	+$48.4K	﹤0.01%	397

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Shay Capital's GDRX Position: Q4 2025 in Review

Shay Capital sold out of GoodRx Holdings (GDRX) in Q4 2025, closing a stake of 11,000 shares — an estimated $46.5K sold.

Shay Capital first reported a position in GDRX in Q3 2025 and held it in 1 quarter. The position peaked at $46.5K in Q3 2025. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

Shay Capital reported no remaining GoodRx Holdings position as of Q4 2025 after selling out during the quarter.
Shay Capital sold 11,000 GoodRx Holdings shares in Q4 2025, an estimated $46.5K.
Shay Capital first reported a position in GoodRx Holdings in Q3 2025 and held it in 1 quarter.
Shay Capital's GoodRx Holdings position peaked at $46.5K in Q3 2025.
183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on Shay Capital's 13F filing for Q4 2025, filed 17 Feb 2026.